Replies to post #400506 on Amarin Corp Plc (AMRN)

[mrmainstreet]

Capt this is why I've said Denner is the only play. It's why I bought more shares down in the $1's when he came on board. If he can get the company ready for sale, and then facilitate a buyout it will be the only path forward that rewards shareholders IMO.

Anything above $5 and I'm satisfied. Anything above $7 I'm happy. Anything at $10 or higher and I will run down the street screaming with joy. My gut says $2-3 billion if Denner manages to take control, but we'll see.

[lizzy241]

capt, good perspective, it's been over 1 1/2 yrs since Sarissa's first purchase. He must have had his eye on Amarin many months before in order for him to perform his due diligence. Maybe we have a couple of years for a turn around assuming Denner wins.
I still don't understand why they retained JPM.

[Nukemtiltheyglow]

Thanks Capt; So it's a process, From yesterdays Post/ interview of Alex Denner and David Faber (CNBC) 2017? AD mentions MEDCO. He also mentioned that MEDCO had several losing drugs that were sold. He said he had to jettison them because they were losing money and it was a drag on the company. He had kept Inclisiran (Leqvio) as it was the only viable drug that had any value. Which we all know Novartis took the bait.
As the case with Amarin, we are relatively simple in comparison. We only have the one viable drug, which in IMHO trumps Inclirsiran. Conversely our timeline will be much shorter than MEDCO's. All in IMHO.

So, using your chart, from March 2018 when Denner gains control of the MEDCO BOD to November 24, 2019, is almost two years. I would guess, we'll see something 6 months to 1 year Max.

[ziploc_1]

Capt...Thanks for the example...Vascepa deserves to be in the pantheon of world class drugs like statins and penicillins...but it needs new management to get it there.